Triple

T16861127
Position Surface form Disambiguated ID Type / Status
Subject Office of Tissues and Advanced Therapies E409911 entity
Predicate jurisdiction P82 FINISHED
Object Federal Food, Drug, and Cosmetic Act E31160 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Federal Food, Drug, and Cosmetic Act | Statement: [Office of Tissues and Advanced Therapies, jurisdiction, Federal Food, Drug, and Cosmetic Act]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Federal Food, Drug, and Cosmetic Act
Context triple: [Office of Tissues and Advanced Therapies, jurisdiction, Federal Food, Drug, and Cosmetic Act]
  • A. Federal Food, Drug, and Cosmetic Act chosen
    The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
  • B. Kefauver–Harris Drug Amendments of 1962
    The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
  • C. Food and Drug Administration Modernization Act of 1997
    The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
  • D. Dietary Supplement Health and Education Act of 1994
    The Dietary Supplement Health and Education Act of 1994 is a U.S. law that defines and regulates dietary supplements as a category of food, setting labeling and safety standards while limiting the FDA’s pre-market approval authority.
  • E. Prescription Drug Marketing Act
    The Prescription Drug Marketing Act is a U.S. federal law that regulates the distribution and marketing of prescription drugs to ensure their safety, effectiveness, and integrity within the pharmaceutical supply chain.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d88395e6c88190b22730f335107c14 completed April 10, 2026, 4:59 a.m.
NER Named-entity recognition batch_69e3b5036e6c8190a3b9e525a34da2e1 completed April 18, 2026, 4:44 p.m.
NED1 Entity disambiguation (via context triple) batch_6a00bb274ba48190951acde0821e05a0 completed May 10, 2026, 5:06 p.m.
Created at: April 10, 2026, 5:24 a.m.